19 results
6-K
EX-1
BLRX
Bioline Rx Ltd
16 Feb 24
Current report (foreign)
7:07am
women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior to initiating treatment with APHEXDA
6-K
EX-99.1
BLRX
Bioline Rx Ltd
17 Apr 24
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4
7:12am
can cause fetal harm. Advise pregnant women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior
6-K
EX-99
BLRX
Bioline Rx Ltd
6 May 24
Current report (foreign)
7:14am
.
Embryo-fetal Toxicity: Based on its mechanism of action, APHEXDA can cause fetal harm. Advise pregnant women of the potential risk to the fetus. Verify
6-K
EX-99
BLRX
Bioline Rx Ltd
11 Sep 23
BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple
7:07am
cause fetal harm. Advise pregnant women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior
F-1
EX-10.17
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
of age, inclusive
· Male or female
· Negative pregnancy test for women of child-bearing potential, or surgically sterile, or post menopausal
· Acute … angiography, MRI or PCI procedures
· Patient taking anti-coagulation medication prior to MI
· Pregnant or lactating women; pregnancy confirmed
20FR12B
EX-4.17
geh9n q69co1h
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20-F
bt2abiv8tlba aer
22 Mar 12
Annual report (foreign)
12:00am
20FR12B/A
ladzm7i08bg5vg
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
cmigo
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
424B3
hljhd
28 Mar 12
Prospectus supplement
12:00am
F-1
a22z2w ntwthjl5thn
24 Sep 10
Registration statement (foreign)
12:00am
424B3
jeb8p6yw5qaog5o6
15 Oct 12
Prospectus supplement
12:00am
20-F/A
7alcj5d
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B3
5vz4 er0pbo
8 Aug 13
Prospectus supplement
12:00am
F-1
oe1uy t60yl21fof
2 Oct 12
Registration statement (foreign)
12:00am
- Prev
- 1
- Next